India's Nutraceutical Market: Growth Drivers and Sourcing Opportunities

What is Driving Demand

Three forces are stacking. First, an ageing demographic (the over-60 cohort grew 35% in the last decade) is creating sustained demand for joint, cardiovascular, and cognitive support formulations. Second, the post-pandemic immunity wave never fully receded — vitamin D, zinc, and immune-modulating botanicals remain top sellers. Third, performance nutrition has gone mass-market, with protein powders and amino-acid supplements now sold through everyday grocery channels rather than specialist stores.

High-Demand Ingredients

Procurement teams should be watching the following categories closely. Demand is outpacing reliable supply in several:

• Vitamin D3 (Cholecalciferol) — fortification mandates plus consumer demand have tripled volumes in five years.
• Coenzyme Q10 — cardiovascular and statin-coadministration use cases.
• Botanical extracts standardised to active markers — Ashwagandha, Curcumin, Boswellia, and Bacopa lead the pack.
• Amino acids (L-Glutamine, L-Arginine, L-Carnitine) for sports nutrition.
• Marine and algal Omega-3 sources — sustainable alternatives to fish-oil-derived DHA/EPA.

FSSAI and the Regulatory Environment

FSSAI 2022 nutraceutical regulations brought the category formally under food law, requiring product-level registration, health-claim substantiation, and adherence to permitted ingredient lists. The upside is regulatory clarity. The downside is that small brands without compliance infrastructure are increasingly squeezed — and that pressure is pushing them toward suppliers who can provide ready-to-use, FSSAI-compliant ingredient documentation as a bundled service.